The Canadian Journal of Psychiatry,
Год журнала:
2024,
Номер
69(9), С. 641 - 687
Опубликована: Май 6, 2024
Background
The
Canadian
Network
for
Mood
and
Anxiety
Treatments
(CANMAT)
last
published
clinical
guidelines
the
management
of
major
depressive
disorder
(MDD)
in
2016.
Owing
to
advances
field,
an
update
was
needed
incorporate
new
evidence
provide
revised
recommendations
assessment
MDD
adults.
Methods
CANMAT
convened
a
editorial
group
comprised
academic
clinicians
patient
partners.
A
systematic
literature
review
conducted,
focusing
on
reviews
meta-analyses
since
2016
guidelines.
Recommendations
were
organized
by
lines
treatment,
which
informed
CANMAT-defined
levels
supplemented
support
(consisting
expert
consensus
safety,
tolerability,
feasibility).
Drafts
based
partners,
peer
review,
defined
process.
Results
updated
comprise
eight
primary
topics,
question-and-answer
format,
that
map
care
journey
from
selection
evidence-based
treatments,
prevention
recurrence,
strategies
inadequate
response.
adopt
personalized
approach
emphasizes
shared
decision-making
reflects
values,
preferences,
treatment
history
with
MDD.
Tables
psychological,
pharmacological,
lifestyle,
complementary
alternative
medicine,
digital
health,
neuromodulation
treatments.
Caveats
limitations
are
highlighted.
Conclusions
2023
evidence-informed
MDD,
clinician-friendly
format.
These
emphasize
collaborative,
personalized,
will
help
optimize
outcomes
adults
Journal of Medical Internet Research,
Год журнала:
2023,
Номер
25, С. e43862 - e43862
Опубликована: Март 10, 2023
Mental
health
problems
are
a
crucial
global
public
concern.
Owing
to
their
cost-effectiveness
and
accessibility,
conversational
agent
interventions
(CAIs)
promising
in
the
field
of
mental
care.
npj Mental Health Research,
Год журнала:
2023,
Номер
2(1)
Опубликована: Авг. 22, 2023
Abstract
This
paper
makes
a
case
for
digital
mental
health
and
provides
insights
into
how
technologies
can
enhance
(but
not
replace)
existing
services.
We
describe
by
presenting
suite
of
(from
interventions
to
the
application
artificial
intelligence).
discuss
benefits
health,
example,
intervention
be
an
accessible
stepping-stone
receiving
support.
The
does,
however,
present
less-discussed
with
new
concepts
such
as
‘poly-digital’,
where
many
different
apps/features
(e.g.
sleep
app,
mood
logging
app
mindfulness
etc.)
each
address
factors
wellbeing,
perhaps
resulting
in
aggregation
marginal
gains.
Another
benefit
is
that
offers
ability
collect
high-resolution
real-world
client
data
provide
monitoring
outside
therapy
sessions.
These
collected
using
phenotyping
ecological
momentary
assessment
techniques
(i.e.
repeated
or
scale
measures
via
app).
allows
tools
inform
therapists
enrich
face-to-face
referred
blended
care/adjunctive
service
users
engage
‘channel
switching’
between
non-digital
(face-to-face)
providing
more
integrated
service.
integration
kind
‘digital
glue’
helps
join
up
in-person
sessions
real
world.
presents
challenges,
majority
apps
are
maybe
inadequate
quality
there
lack
user
retention.
There
also
ethical
perceived
‘over-promotion’
screen-time
reduction
care
when
replacing
humans
‘computers’,
trap
‘technological
solutionism’
whereby
technology
naively
presumed
solve
all
problems.
Finally,
we
argue
need
take
evidence-based,
systems
thinking
co-production
approach
form
stakeholder-centred
design
developing
services
based
on
technologies.
main
contribution
this
ideas
from
disciplines
well
framework
showcase
physical
emergence
‘poly-digital’
discussion
challenges
specifically
ethics’.
World Psychiatry,
Год журнала:
2024,
Номер
23(1), С. 139 - 149
Опубликована: Янв. 12, 2024
The
mental
health
care
available
for
depression
and
anxiety
has
recently
undergone
a
major
technological
revolution,
with
growing
interest
towards
the
potential
of
smartphone
apps
as
scalable
tool
to
treat
these
conditions.
Since
last
comprehensive
meta‐analysis
in
2019
established
positive
yet
variable
effects
on
depressive
symptoms,
more
than
100
new
randomized
controlled
trials
(RCTs)
have
been
carried
out.
We
conducted
an
updated
objectives
providing
precise
estimates
effects,
quantifying
generalizability
from
this
evidence
base,
understanding
whether
app
trial
characteristics
moderate
effect
sizes.
included
176
RCTs
that
aimed
or
symptoms.
Apps
had
overall
significant
although
small
symptoms
(N=33,567,
g=0.28,
p<0.001;
number
needed
treat,
NNT=11.5)
generalized
(N=22,394,
g=0.26,
p<0.001,
NNT=12.4)
compared
control
groups.
These
were
robust
at
different
follow‐ups
after
removing
sample
higher
risk
bias
trials.
There
was
less
variability
outcome
scores
post‐test
conditions
(ratio
variance,
RoV=–0.14,
95%
CI:
–0.24
–0.05
symptoms;
RoV=–0.21,
–0.31
–0.12
symptoms).
Effect
sizes
significantly
larger
when
incorporated
cognitive
behavioral
therapy
(CBT)
features
chatbot
technology.
primary
target
administered
CBT
mood
monitoring
features.
found
social
(g=0.52)
obsessive‐compulsive
(g=0.51)
post‐traumatic
stress
(g=0.12),
large
acrophobia
(g=0.90),
non‐significant
negative
panic
(g=–0.12),
results
should
be
considered
caution,
because
most
high
based
conclude
but
anxiety,
specific
–
such
technology
are
associated
The Canadian Journal of Psychiatry,
Год журнала:
2024,
Номер
69(9), С. 641 - 687
Опубликована: Май 6, 2024
Background
The
Canadian
Network
for
Mood
and
Anxiety
Treatments
(CANMAT)
last
published
clinical
guidelines
the
management
of
major
depressive
disorder
(MDD)
in
2016.
Owing
to
advances
field,
an
update
was
needed
incorporate
new
evidence
provide
revised
recommendations
assessment
MDD
adults.
Methods
CANMAT
convened
a
editorial
group
comprised
academic
clinicians
patient
partners.
A
systematic
literature
review
conducted,
focusing
on
reviews
meta-analyses
since
2016
guidelines.
Recommendations
were
organized
by
lines
treatment,
which
informed
CANMAT-defined
levels
supplemented
support
(consisting
expert
consensus
safety,
tolerability,
feasibility).
Drafts
based
partners,
peer
review,
defined
process.
Results
updated
comprise
eight
primary
topics,
question-and-answer
format,
that
map
care
journey
from
selection
evidence-based
treatments,
prevention
recurrence,
strategies
inadequate
response.
adopt
personalized
approach
emphasizes
shared
decision-making
reflects
values,
preferences,
treatment
history
with
MDD.
Tables
psychological,
pharmacological,
lifestyle,
complementary
alternative
medicine,
digital
health,
neuromodulation
treatments.
Caveats
limitations
are
highlighted.
Conclusions
2023
evidence-informed
MDD,
clinician-friendly
format.
These
emphasize
collaborative,
personalized,
will
help
optimize
outcomes
adults